Analyst Downgrades

• RBC Capital downgraded Myriad Genetics (NASDAQ: MYGN) to Sector Perform from Outperform after the company preannounced lower than expected Q4 results. RBC lowered its target on shares to $35 from $45. Oppenheimer downgraded Myriad to Perform from Outperform.
• Citigroup downgraded CardioNet (NASDAQ: BEAT) to Hold from Buy after the company lowered guidance for FY09 and rescinded out-year projections. The firm lowered its target on shares to $18 from $29.
• Piper downgraded AtriaCure (NASDAQ: ATRC) to Underweight from its previous Buy rating after changing its rating system. The firm has a $4 target on shares.
• Check Point (NASDAQ: CHKP) was downgraded to Neutral from Overweight at JPMorgan.
• Pervasive Software (NASDAQ: PVSW) was downgraded to Neutral from Buy at B. Riley.
• Starwood Hotels (NYSE: HOT) was downgraded to Underweight from Equal Weight at Barclays.
• Westpac Banking (NYSE: WBK) was downgraded to Underperform from Neutral at Credit Suisse.

Analyst Initiations

• Kaufman Bros. finds Palm's (NASDAQ: PALM) valuation expensive at current levels and is concerned about the continued operating losses. The firm started shares with a Hold rating and $16 target.
• Jefferies initiated Energy Recovery (NASDAQ: ERII) with a Hold rating and $7.60 target and recommends investors wait for a better entry point into shares.
• Kaufman Bros. believes Affiliated Computer (NYSE: ACS) could disappoint in FY10. Shares were initiated with a Hold rating and $48 target.
• Nasdaq (NASDAQ: NDAQ) was initiated with a Market Perform rating at William Blair.
• Kinetic Concepts (NYSE: KCI) was initiated with a Neutral rating at Susquehanna.
• Symantec (NASDAQ: SYMC) was initiated with an Outperform rating and $20 target at JMP Securities.